Enjoy complimentary customisation on priority with our Enterprise License!
The needle-free injection systems market size is estimated to grow by USD 20.15 billion at a CAGR of 16.83% between 2023 and 2028. The increasing preference for minimally invasive biopsies is driving the market growth. For screening and diagnosis of various types of cancer, like bone cancer, biopsies are used. The traditional biopsy procedure is still widely used; however, it is invasive and can cause complications like bruising, swelling, bleeding, and infections. To prevent these complications, needle-free injections have emerged as an alternative; they involve non-invasive procedures to detect certain molecular biomarkers for the early detection of diseases in patients. They also have the advantages of quick results and minimal risks involved. All these features are expected to have a positive impact on the demand for needle-free injection systems.
To learn more about this report, Request Free Sample
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.